HK1031872A1 - Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia. - Google Patents
Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia.Info
- Publication number
- HK1031872A1 HK1031872A1 HK01102397A HK01102397A HK1031872A1 HK 1031872 A1 HK1031872 A1 HK 1031872A1 HK 01102397 A HK01102397 A HK 01102397A HK 01102397 A HK01102397 A HK 01102397A HK 1031872 A1 HK1031872 A1 HK 1031872A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- phtalimido
- arylpiperazines
- alpha
- treatment
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7551098P | 1998-02-20 | 1998-02-20 | |
| PCT/US1999/003694 WO1999042445A1 (en) | 1998-02-20 | 1999-02-19 | Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1031872A1 true HK1031872A1 (en) | 2001-06-29 |
Family
ID=22126243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK01102397A HK1031872A1 (en) | 1998-02-20 | 2001-04-03 | Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia. |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20020077476A1 (de) |
| EP (1) | EP1056720B1 (de) |
| JP (1) | JP2002503722A (de) |
| KR (1) | KR100608473B1 (de) |
| CN (1) | CN1172911C (de) |
| AR (1) | AR015521A1 (de) |
| AT (1) | ATE280156T1 (de) |
| AU (1) | AU766411B2 (de) |
| BR (1) | BR9908122A (de) |
| DE (1) | DE69921300T2 (de) |
| ES (1) | ES2233023T3 (de) |
| HK (1) | HK1031872A1 (de) |
| HU (1) | HUP0100704A3 (de) |
| IL (2) | IL137953A0 (de) |
| NO (1) | NO317104B1 (de) |
| NZ (1) | NZ506461A (de) |
| PL (1) | PL194649B1 (de) |
| PT (1) | PT1056720E (de) |
| TR (1) | TR200003224T2 (de) |
| WO (1) | WO1999042445A1 (de) |
| ZA (1) | ZA991319B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20010164A1 (it) * | 2001-01-30 | 2002-07-30 | Recordati Chem Pharm | Alfa 1 antagonisti selettivi a + d |
| CN103387531A (zh) * | 2012-05-10 | 2013-11-13 | 广州医学院 | 酰胺类芳基哌嗪衍生物及其制备方法和在抗良性前列腺增生中的应用 |
| HUP1400294A2 (hu) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Clopidogrel új alkalmazása |
| CN105061434B (zh) * | 2015-07-30 | 2017-07-21 | 新发药业有限公司 | 一种西他列汀磷酸盐的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1382742A (en) | 1972-09-19 | 1975-02-05 | Labaz | Benzofuran derivatives and process for preparing the same |
| CH585693A5 (de) | 1974-02-08 | 1977-03-15 | Ciba Geigy Ag | |
| HU177702B (en) | 1977-10-24 | 1981-12-28 | Noevenyvedelmi Kutato Intezet | Plant growth regulator and process for preparing the active materials |
| PT82077B (fr) * | 1985-02-26 | 1987-09-25 | Sanofi Sa | Procede pour l'obtention des derives aminoalcools peptidiques inhibiteurs de la renine et des proteases acides |
| FR2678271B1 (fr) * | 1991-06-27 | 1995-01-13 | Synthelabo | Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
| US5428037A (en) * | 1993-04-09 | 1995-06-27 | Syntex Pharmaceuticals, Ltd. | Heterocyclic derivatives in the treatment of Ischaemia and related diseases |
| DK0984777T3 (da) * | 1997-05-12 | 2003-12-08 | Ortho Mcneil Pharm Inc | Arylsubstituerede piperaziner, der er anvendelige ved behandlingen af godartet prostatisk hyperplasi |
-
1999
- 1999-02-18 ZA ZA9901319A patent/ZA991319B/xx unknown
- 1999-02-19 NZ NZ506461A patent/NZ506461A/en unknown
- 1999-02-19 HU HU0100704A patent/HUP0100704A3/hu unknown
- 1999-02-19 IL IL13795399A patent/IL137953A0/xx active IP Right Grant
- 1999-02-19 ES ES99908303T patent/ES2233023T3/es not_active Expired - Lifetime
- 1999-02-19 AT AT99908303T patent/ATE280156T1/de not_active IP Right Cessation
- 1999-02-19 WO PCT/US1999/003694 patent/WO1999042445A1/en active IP Right Grant
- 1999-02-19 PL PL99342357A patent/PL194649B1/pl not_active IP Right Cessation
- 1999-02-19 AU AU27765/99A patent/AU766411B2/en not_active Ceased
- 1999-02-19 EP EP99908303A patent/EP1056720B1/de not_active Expired - Lifetime
- 1999-02-19 KR KR1020007009159A patent/KR100608473B1/ko not_active IP Right Cessation
- 1999-02-19 CN CNB998030260A patent/CN1172911C/zh not_active Expired - Fee Related
- 1999-02-19 TR TR2000/03224T patent/TR200003224T2/xx unknown
- 1999-02-19 BR BR9908122-9A patent/BR9908122A/pt not_active Application Discontinuation
- 1999-02-19 JP JP2000532397A patent/JP2002503722A/ja not_active Withdrawn
- 1999-02-19 PT PT99908303T patent/PT1056720E/pt unknown
- 1999-02-19 DE DE69921300T patent/DE69921300T2/de not_active Expired - Fee Related
- 1999-02-23 AR ARP990100676A patent/AR015521A1/es active IP Right Grant
-
2000
- 2000-08-18 NO NO20004142A patent/NO317104B1/no not_active IP Right Cessation
- 2000-08-18 IL IL137953A patent/IL137953A/en not_active IP Right Cessation
-
2001
- 2001-04-03 HK HK01102397A patent/HK1031872A1/xx not_active IP Right Cessation
- 2001-12-11 US US10/014,979 patent/US20020077476A1/en not_active Abandoned
-
2002
- 2002-07-29 US US10/207,473 patent/US6780994B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1172911C (zh) | 2004-10-27 |
| NO317104B1 (no) | 2004-08-09 |
| IL137953A (en) | 2006-12-31 |
| TR200003224T2 (tr) | 2001-03-21 |
| ATE280156T1 (de) | 2004-11-15 |
| AR015521A1 (es) | 2001-05-02 |
| PL342357A1 (en) | 2001-06-04 |
| AU2776599A (en) | 1999-09-06 |
| KR20010041118A (ko) | 2001-05-15 |
| PL194649B1 (pl) | 2007-06-29 |
| HUP0100704A2 (hu) | 2001-10-28 |
| AU766411B2 (en) | 2003-10-16 |
| WO1999042445A1 (en) | 1999-08-26 |
| CN1291185A (zh) | 2001-04-11 |
| HUP0100704A3 (en) | 2002-10-28 |
| EP1056720A1 (de) | 2000-12-06 |
| US20030088099A1 (en) | 2003-05-08 |
| DE69921300T2 (de) | 2006-03-09 |
| ZA991319B (en) | 2000-11-20 |
| NO20004142L (no) | 2000-10-19 |
| PT1056720E (pt) | 2005-02-28 |
| EP1056720B1 (de) | 2004-10-20 |
| DE69921300D1 (de) | 2004-11-25 |
| KR100608473B1 (ko) | 2006-08-09 |
| US6780994B2 (en) | 2004-08-24 |
| NO20004142D0 (no) | 2000-08-18 |
| NZ506461A (en) | 2003-08-29 |
| ES2233023T3 (es) | 2005-06-01 |
| BR9908122A (pt) | 2001-11-13 |
| US20020077476A1 (en) | 2002-06-20 |
| JP2002503722A (ja) | 2002-02-05 |
| IL137953A0 (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5093A (is) | Kínólín og kínasólín efnasambönd nytsamleg í meðferð, einkum til að meðhöndla góðkynja vefjaauka í blöðruhálskirtli | |
| MXPA03009720A (es) | USO DE ANTAGONISTAS DEL RECEPTOR DE NK-1 PARA TRATAMIENTO O PREVENCIoN DE HIPERPLASIA PROSTATICA BENIGNA. | |
| HUP9903732A3 (en) | Use of cgmp elevators for the preparation of pharmaceutical compositions treating benign prostatic hyperplasia | |
| DE60023982D1 (de) | System zur Behandlung von benigner Prostatahyperplasie | |
| HUP0200442A3 (en) | Azeotrope-like composition comprising 1,1,1,3,3-pentafluorobutane and its use | |
| IL141235A0 (en) | Combined use of an alpha-adrenoceptor antagonist and amuscarinic antagonist in the treatment of benign prostatic hyperplasi | |
| AU1316000A (en) | Compositions and methods for treating benign prostatic hyperplasia using tocotrienols | |
| DK0925069T3 (da) | Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer | |
| IL120494A0 (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
| EP0855910A4 (de) | Verwendbare konjugate zur behandlung der gutartigen prostatehyperplasie | |
| ZA991315B (en) | Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia. | |
| ZA983968B (en) | Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia. | |
| AU6228000A (en) | The use of retinoid receptor antagonists in the treatment of prostate carcinoma | |
| HK1031872A1 (en) | Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia. | |
| ZA982819B (en) | Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators. | |
| AP2000001950A0 (en) | Paroxetine maleate. | |
| IT1283124B1 (it) | Forme e composizioni farmaceutiche per il trattamento dell'ipertrofia prostatica benigna | |
| DK1056720T3 (da) | Phtalimido-arylpiperaziner som alfa-1A-receptorantagonister, der er nyttige til behandling af godartet prostatahyperplasi | |
| EP0748627A3 (de) | Melatoninagonisten zur Behandlung von gutartigen Hyperplasieformen der Prostata | |
| EP1140906A4 (de) | Imidazolone und ihre anwendung bei der behandlung von benigner prostatahyperplasie und anderen störungen | |
| GB9602903D0 (en) | Conjugates useful in the treatment of benign prostatic hyperplasia | |
| AU782863C (en) | The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions | |
| GB9810895D0 (en) | Combination therapy for the treatment of benign prostatic hyperplasia | |
| HK1045506A1 (en) | Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods | |
| ECSP982362A (es) | Compuestos de quinolina y quinazolina utiles en terapia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100219 |